After finishing at $0.60 in the prior trading day, VBI Vaccines Inc. (NASDAQ: VBIV) closed at $0.58, down -3.33%. On the day, 505812 shares were traded.
Ratios:
Our goal is to gain a better understanding of VBIV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.55 and its Current Ratio is at 0.65. In the meantime, Its Debt-to-Equity ratio is 2.65 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Raymond James on November 11, 2022, Downgraded its rating to Outperform and sets its target price to $2 from $5 previously.
On February 25, 2021, Jefferies started tracking the stock assigning a Buy rating and target price of $7.Jefferies initiated its Buy rating on February 25, 2021, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 10 ’23 when GILLIS STEVEN bought 609,090 shares for $1.65 per share. The transaction valued at 1,004,998 led to the insider holds 1,043,292 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.69 while its Price-to-Book (P/B) ratio in mrq is 0.68.
Stock Price History:
Over the past 52 weeks, VBIV has reached a high of $4.45, while it has fallen to a 52-week low of $0.45.
Shares Statistics:
A total of 23.69M shares are outstanding, with a floating share count of 22.28M. Insiders hold about 5.94% of the company’s shares, while institutions hold 12.26% stake in the company.
Earnings Estimates
Its stock is currently analyzed by VBI Vaccines, Inc. different market analysts.
EPS for the following year is $Stocks, with Stocks analysts recommending between $Index and $ETF.
